Editorial Board

Philip D. Bonomi, MD

Director, Section of Medical Oncology
Alice Wirtz Professor of Medicine
Rush-Presbyterian St. Luke’s Medical Center
Chicago, Illinois

Michael S. Gordon, MD

Associate Professor of Medicine
University of Arizona College of Medicine
Phoenix, Arizona

Julie R. Gralow, MD

Assistant Professor of Medical Oncology
University of Washington
Associate Professor
Fred Hutchinson Cancer Research Center
Seattle, Washington

Mark D. Pegram, MD

Associate Professor of Medicine
David Geffen School of Medicine at UCLA
Director, Women's Cancer Program
UCLA/Jonsson Comprehensive Cancer Center
Santa Monica, California

Mark A. Socinski, MD

Associate Professor of Medicine
Multidisciplinary Thoracic Oncology Program
Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, North Carolina

Nicholas J. Vogelzang, MD

Director, Nevada Cancer Institute
Las Vegas, Nevada

Louis M. Weiner, MD

Vice President, Translational Research
Chairman, Department of Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

ATCT CME Activities

Promising Targeted Modalities in NSCLC

Rafael Rosell, MD

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Albert Einstein College of Medicine designates each educational activity for a maximum of 1 Category 1 Credit toward the AMA Physician’s Recognition Award. Each physician should claim those credits that he/she actually spent in the educational activity.

These CME activities were planned and produced in accordance with the ACCME Essentials.

Editorial Board

Philip D. Bonomi, MD

Michael S. Gordon, MD

Julie R. Gralow, MD

Mark D. Pegram, MD

Mark A. Socinski, MD

Nicholas J. Vogelzang, MD

Louis M. Weiner, MD

Current Issue

Feature

Notes & Commentary

Reviews & Reports

Digest

ATCT Article Reprints

Slides

Search Previous Issues

ATCT CME Activities

Promising Targeted Modalities in NSCLC